We are live on ! Find out more
JSPR icon

Jasper Therapeutics

10 hedge funds and large institutions have $102M invested in Jasper Therapeutics in 2021 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 53 closing their positions.

New
Increased
Maintained
Reduced
Closed

24% more capital invested

Capital invested by funds: $82.2M → $102M (+$20M)

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

82% less funds holding

Funds holding: 5710 (-47)

89% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 53

Holders
10
Holders Change
-47
Holders Change %
-82.46%
% of All Funds
0.18%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
2
Reduced
2
Closed
53
Calls
Puts
Net Calls
Net Calls Change

JSPR Hedge Fund Activity: Q3 2021 in Review

10 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Jasper Therapeutics (JSPR) for Q3 2021, worth a combined $102M — up 24% from $82.2M a quarter earlier.

Sellers outnumbered buyers: 53 funds closed out of JSPR and 6 opened new positions — a net loss of 47 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was Abingworth, opening a new position worth an estimated $57.5M. The largest seller was Mizuho Securities USA, exiting entirely with an estimated $6.49M sold.

  • 10 institutional investors held Jasper Therapeutics (JSPR) as of Q3 2021, down from 57 in Q2 2021.
  • Funds reported $102M of Jasper Therapeutics stock for Q3 2021, up 24% quarter-over-quarter.
  • 6 funds opened new Jasper Therapeutics positions in Q3 2021 and 53 closed out, a net change of -47 holders.
  • The largest Jasper Therapeutics buyer in Q3 2021 was Abingworth, an estimated $57.5M added.
  • The largest Jasper Therapeutics seller in Q3 2021 was Mizuho Securities USA, an estimated $6.49M sold.

Based on aggregated 13F filings for Q3 2021.